Search results

5 items matching your search terms.
Filter the results.
Item type

New items since

Sort by relevance · date (newest first) · alphabetically
UNC researchers discover new target for dengue virus vaccine
By re-engineering a tiny chain of amino acids in one type of dengue virus, Ralph Baric and Aravinda de Silva discover a new path toward solving the dengue vaccine dilemma. The research has the potential to transform vaccine development for other diseases, including SARS and HIV.
Located in News / 2014 / February
Measles outbreak sparks national debate
Pediatric infectious diseases specialist, Dr. Ravi Jhaveri, speaks out on the U.S. measles outbreak.
Located in UNC Children's News / News
Vaccines provide needed defense against disease
Following a controversy in the Wake County Schools, reporters visited UNC Children's to find that physicians think that any possible drawbacks to vaccinations are far outweighed by the benefits.
Located in UNC Children's News / News / 2016
Vaccinations A Vital Part of Back-to-School Season
Back to school time is also time to visit your physician's office - to make sure your child's vaccinations are current.
Located in UNC Children's News / / 2017 / July 2017
Can nanotechnology help develop a workable dengue virus vaccine?
UNC School of Medicine researchers Aravinda de Silva, PhD, professor of microbiology and immunology, and Stefan Metz, PhD, are creating a nanoparticle vaccine that in experiments showed increased antibody responses against one serotype of dengue virus. The de Silva group is collaborating with the UNC laboratories of Chris Luft, PhD, (pharmacy and chemistry), Jenny Ting, PhD, (genetics), and Mike Miley,PhD, (pharmacology), as well as Liquidia Pharmaceuticals to use the same nanoparticle platform to develop a vaccine for all four serotypes of the virus.
Located in News / 2016 / November